The serum galectin-3 level was measured, classified into two groups according to the median galectin-3 level (9.52 ng/ml, interquartile range 7.31–12.81), and compared with the composite of all-cause mortality, non-fatal myocardial infarction (MI), and stroke. Here, LGALS3 is linked to stroke disorder.